15 July 2022 | News
Provides everything needed for AI drug discovery, from models for property prediction and molecular design to AI consulting and implementation support
Image credit: shutterstock
Japan-based startup Elix, Inc., an artificial intelligenet (AI) drug discovery company with the mission of “Rethinking Drug Discovery” has launched “Elix Discovery,” the only all-in-one platform that provides everything needed for AI drug discovery, from models for property prediction and molecular design to AI consulting and implementation support.
Drug discovery using artificial intelligence (AI) and machine learning is attracting attention to shorten the time required for drug discovery, reduce associated costs, and improve success rates. However, pharmaceutical companies face major barriers in the adoption of AI due to insufficient knowledge of AI technology, difficulty in understanding how to use existing AI tools, lack of an intuitive and integrated platform, and the need to consider the best way to utilize AI for each specific drug discovery project.
Elix Discovery is the only all-in-one platform that provides a wide selection of AI models, intuitive Graphical User Interface (GUI), expert implementation support and consulting, and knowledge for AI drug discovery. The platform provides essential features for AI drug discovery, and will continue to grow from ongoing updates as new developments are made in the ever-evolving AI field. While many AI companies are secretive and do not disclose their knowledge and methods to clients, Elix, Inc. values transparency and openly shares knowledge with our clients to help them accumulate experience in AI drug discovery.